Evidence map›Paper›PMID 39479331›Full record

ArticleJACC. CardioOncology2024

Carvedilol to Improve Cardiac Remodeling in Anthracycline-Exposed Childhood Cancer Survivors: Subgroup Analysis of COG ALTE1621.

Saro H Armenian, Melissa M Hudson, Lanie Lindenfeld, Sitong Chen, Eric J Chow, Steven Colan, Meagan Echevarria, F Lennie Wong, Ming Hui Chen, Smita Bhatia

Abstract read
In one paragraph

Article in JACC. CardioOncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Management of late toxicities and specific follow-up needs of adolescent and young adult cancer survivors: recommendations from scientific societies in Spain.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Saro H ArmenianDivision of Outcomes Research, City of Hope, Duarte, California, USA.
Melissa M HudsonDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Lanie LindenfeldDivision of Outcomes Research, City of Hope, Duarte, California, USA.
Sitong ChenDivision of Outcomes Research, City of Hope, Duarte, California, USA.
Eric J ChowClinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Steven ColanDepartment of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
Meagan EchevarriaDivision of Outcomes Research, City of Hope, Duarte, California, USA.
F Lennie WongDivision of Outcomes Research, City of Hope, Duarte, California, USA.
Ming Hui ChenDepartment of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
Smita BhatiaInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG FOREIGN ACCRUALU10CA098543 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI ADAMSON, PETER C. · 2003 to 2013
$335.5M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Towards a preventive cancer vaccine for children with constitutional mismatch repair deficiencyUG1CA189955 · NCI · PUBLIC HEALTH INSTITUTE · PI BRAD H POLLOCK, Michael E. Roth · 2014 to 2026
$62.5M
Oncology Research Career Development ProgramK12CA001727 · NCI · CITY OF HOPE NATIONAL MEDICAL CENTER · PI MORTIMER, JOANNE E. · 1992 to 2024
$14.6M
Cardiovascular reserve capacity in survivors of hematopoietic cell transplantationR01HL150069 · NHLBI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI ARMENIAN, SARO · 2020 to 2024
$3.5M
Reducing risk of Anthracycline-related heart failure after childhood cancerR01CA196854 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI ARMENIAN, SARO · 2015 to 2019
$3.2M
NCI NIH HHS K12 CA001727NCI NIH HHS R01 CA196854NCI NIH HHS U10 CA098543NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899NHLBI NIH HHS R01 HL150069
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerscancer survivorshipcardiomyopathyechocardiographyprevention

Identifiers

PMID39479331
PMCPMC11522501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.